Nuclear targeting of FBPase in HL-1 cells is controlled by beta-1 adrenergic receptor-activated Gs protein signaling cascade  by Gizak, Agnieszka et al.
Biochimica et Biophysica Acta 1793 (2009) 871–877
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrNuclear targeting of FBPase in HL-1 cells is controlled by beta-1 adrenergic
receptor-activated Gs protein signaling cascade
Agnieszka Gizak ⁎, Marek Zarzycki, Dariusz Rakus
Department of Animal Molecular Physiology, Wroclaw University, Cybulskiego 30, 50-205 Wroclaw, Poland⁎ Corresponding author. Tel.: +48 71 375 95 38; fax:
E-mail address: agizak@biol.uni.wroc.pl (A. Gizak).
0167-4889/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbamcr.2009.02.005a b s t r a c ta r t i c l e i n f oArticle history: Muscle fructose 1,6-bispho
Received 21 November 2008
Received in revised form 29 January 2009
Accepted 12 February 2009
Available online 27 February 2009
Keywords:
Muscle FBPase
HL-1 cell
Norepinephrine
Protein kinase A
Phosphoinositide 3-kinasesphatase (FBPase), a well-known regulatory enzyme of glyconeogenic pathway
has recently been found inside nuclei of several cell types (cardiomyocytes, smooth muscle cells, myogenic
progenitor cells). This surprising ﬁnding raised a question concerning the role of FBPase in this compartment
of the cell, and of the extracellular signals regulating nuclear transport of the enzyme. In the present paper
we show that, in HL-1 cardiomyocyte cell line, the activity of adenylyl cyclase and cAMP-dependent protein
kinase A is essential to nuclear import of FBPase. The import is also stimulated by isoproterenol (a
nonselective β-adrenergic receptors agonist) and inhibited by metoprolol (a selective β1 antagonist),
strongly suggesting that nucleo-cytoplasmic shuttling of FBPase is under the control of β1-adrenergic
receptor-dependent Gs protein signaling cascade.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Fructose 1,6-bisphosphatase (FBPase; EC 3.1.3.11) catalyses the
irreversible reaction of hydrolysis of fructose 1,6-bisphosphate to
fructose 6-phosphate and inorganic phosphate [1]. Genetic and
kinetic studies so far have demonstrated that at least two distinct
isoenzymes of FBPase exist in vertebrates [2–4]: the liver isozyme –
which is the regulatory enzyme of gluconeogenesis [2], and the
muscle isozyme – which participates in glycogen synthesis from
carbohydrate precursors [5], but its physiological role is not yet fully
understood. In contrast to its liver isozyme, muscle FBPase is highly
sensitive to inhibition by AMP and calcium ions [2,6–9], and it is
presumed that the isozyme may be catalytically active and participate
in glycogen synthesis from non-glucidic precursors only upon
association with the muscle isoform of aldolase [6,8,10]. Unlike the
liver FBPase, the muscle isoform is widely expressed, both in cells
which are not known to synthesize glycogen from carbohydrate
precursors (e.g. neurons, [11]) and in cells which predominantly
express the liver isozyme (e.g. liver, [3]). The role of muscle FBPase in
these tissues remains unexplained.
Quite recently we have presented evidence that FBPase is present
inside the cells' nuclei in cardiomyocytes, in smooth muscle cells, and
in dividing muscle satellite cells [7,12–14]. Such unexpected nuclear
localization of muscle FBPase seems to accompany the cells' potential
to divide, while cytoplasm-restricted localization of the enzyme+48 71 375 92 13.
ll rights reserved.appears to characterize terminally differentiated cells [14]. This might
suggest that, in addition to its ‘classic’ glyconeogenic role in
cytoplasm, muscle FBPase participates in some nuclear processes
during division and regeneration of muscle cells [14] and should be
considered another member of the growing family of multifaceted
proteins [15]. On the other hand, parallel studies of Slebe's group
demonstrated that the liver gluconeogenic isozyme may also localize
within cells' nuclei, however, such localization depends mainly on the
metabolic state of the cells and is modulated by glucose, dihydrox-
yacetone and insulin [16].
Our preliminary experiments revealed that changes in glucose
concentration (within the physiological range) have no effect on the
nuclear localization of muscle FBPase. Consequently, to address the
question concerning the nuclear role of the isozyme in non-gluconeo-
genic tissueswehave sought to identify the signalingpathways engaged
in the reversible FBPase targeting to the nucleus. In our experiments we
have used the murine cardiomyocyte cell line HL-1, ﬁrst established by
Dr. W.C. Claycomb [17]. The immortalized HL-1 cardiomyocytes
continuously divide and spontaneously contract, while maintaining
adult cell phenotype, and as such they can be used to study normal
cardiomyocyte function with regard to signaling, metabolic and
transcriptional regulation [17,18].
Results of our studies indicate that, in HL-1 cardiomyocytes,
nuclear transport of FBPase is mediated by norepinephrine, acting
through β1 receptors and the Gs protein signaling cascade, involving
cAMP-dependent protein kinase (PKA). Nuclear transport is also
inﬂuenced by the activity of phosphoinositide 3-kinase (PI3K). The
physiological meaning of these ﬁndings is discussed.
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2.1. Chemicals
Unless stated otherwise, all chemicals were from Sigma-Aldrich
and were of the cell culture grade.
2.2. Antibody production
Rabbit polyclonal antibodies against muscle FBPase were produced
and puriﬁed as described previously [12,13]. To check speciﬁcity of the
antibodies, immunoblotting was performed as described by Towbin et
al. [19] using extract from HL-1 cells and puriﬁed muscle FBPase as a
control.
2.3. Cell culture
HL-1 cardiomyocytes were presented by Dr. W.C. Claycomb
(Louisiana State University Health Science Center, New Orleans, LA,
USA), who ﬁrst established and characterized the cell line [17].
The cells were handled as described in [18]. All culture dishes and
ﬂasks were pre-coated with gelatin-ﬁbronectin substrate. Cardiomyo-
cytes were plated two days before experiments, at the density of
2.5×104 cells/cm2, and maintained in the Claycomb Medium™ (JHR
Biosciences) supplemented with 10% fetal bovine serum (JHR
Biosciences), 2 mM L-glutamine 0.1 mM norepinephrine and peni-
cillin–streptomycin (100 U/ml:100 μg/ml) [18]. The medium was
changed approximately every 24 h. The cells were incubated at 37°C,
in a humidiﬁed atmosphere of 5% CO2 and 95% air.
After 2 days of culture, in half of the culture dishes themediumwas
exchanged for a norepinephrine-free medium. After 3–48 h of
incubation cells were ﬁxed and localization of FBPase was examined.
For quantitative purposes, and to determine viability of HL-1 cells,
they were detached from the culture ﬂask by trypsinization, pelleted
by centrifugation 500 ×g for 5 min, re-suspended in a serum-free
mediumwith addition of 0.4% Trypan Blue and counted in Thom–Zeiss
chamber.
2.4. Isoproterenol and metoprolol stimulation
To deﬁne the signal transduction pathway involved in FBPase
targeting to the nucleus, cardiomyocytes were preincubated for 48 h
with either a serum-and-norepinephrine-free medium, or only
serum-free medium, and then treated, respectively, with isoproter-
enol (ISO, a nonselective β-adrenergic agonist; 5–20 μM, 24 h) or
metoprolol (MTP, a selective β1 antagonist; 1–10 μM, 24 h).
Some of the cells were deprived of serum and norepinephrine,
then treated with ISO as described above, and subsequently incubated
with MTP or Leptomycin B (LMB, an inhibitor of the nuclear export;
10 ng/ml) and MTP. The cells were then ﬁxed, and the subcellular
localization of FBPase was examined using immunocytochemistry and
ﬂuorescence microscopy.
2.5. Forskolin and PKA
Two days after plating, the standard culture medium was replaced
with a serum-and-norepinephrine-free medium. After 48 h of culture,
cells were treatedwith 10 μM forskolin for 24 h and thenwere incubated
with freshmediumwith forskolin for anadditional hour. In order to check
the role of PKA activity, cells were maintained in serum-free medium,
followedbya24-hour incubation in a serum-freemediumsupplemented
with 2 μM KT 5720, a PKA inhibitor. The cells were then incubated with
fresh mediumwith PKA inhibitor for an additional hour. Cells incubated
with the serum-free medium and serum-and-norepinephrine-free
medium served as controls. The cells were ﬁxed, and the localization of
FBPase was examined using immunoﬂuorescence methods.2.6. Phosphoinositide 3-kinase (PI3K) inhibition
The cells were treated as described above for PKA inhibition. To
inhibit the activity of PI3K, 1 μM wortmannin was used.
2.7. Immunocytochemistry and ﬂuorescence microscopy
Cells growing on gelatin-ﬁbronectin-coated coverslips were ﬁxed
with 3% paraformaldehyde in PBS pH 7.3 for 10 min. and permeabilized
with 0.1% Triton X-100 for 3 min. in room temperature. Non-speciﬁc
antibody binding sites were blocked by incubation of the cells in 3% BSA
in PBS, 30 min. at 4°C. The cells were then incubated with rabbit anti-
muscle FBPase primary antibody (1:400) and with anti-rabbit FITC-
conjugated secondaryantibody (1:400dilution). In control reactions the
primary antibodywasomitted, or normal serumwasused as aﬁrst layer.
Cells were embedded in Fluorescent Mounting Medium (Dako) and
examined with the Olympus IX71 ﬂuorescence microscope equipped
with a ColorView IIIu Soft Imaging System (Olympus).
2.8. RT-PCR
Total RNA of 2×106 HL-1 cells was prepared using GeneElute™
Mammalian Total RNA Kit. 3 μg of the RNA was transcribed into cDNA
with Enhanced Avian HS RT-PCR Kit (Sigma). The resulting cDNA was
used as a PCR template in a reaction mixture containing: 2.5 U of
JumpStart Accu Taq LA DNA polymerase, 5 mM Tris–HCl (pH 9.3),
2.5 mM MgCl2, 15 mM ammonium sulfate, 0.1% Tween 20, 2% DMSO,
dNTPs (each 0.4 mM) and appropriate mouse-FBPase-speciﬁc primers
(each 0.5 μM). To screen the expression of FBPase isozymes inHL-1 cells,
muscle and liver mouse-FBPase-speciﬁc primers (MuscMoFor3: 5′-
CAAAgggACCggAgAACTCAC and LivMoFor: 5′-gAACCATgCgCCCTTC-
gAAAC, for the muscle and the liver isozyme, respectively) and
MouseRev (5′-CATCCTTCTCAgAAggCTCATC) were used as reverse
primers targeting a region common to both of the mouse-FBPase
isozymes. Thirty-ﬁve PCR cycles were performed, each consisting of
denaturation at 94 °C for 1 min., annealing at 60 °C for 1 min., and
extension at 72 °C for 1 min. The speciﬁcity of the primers was tested
using cDNA prepared from mouse liver and muscle tissues (data not
shown). PCR-derived DNA fragments were electrophoresed on 2%
agarose gel supplemented with 0.01% ethidium bromide and examined
under UV light.
2.9. Activity measurement
Tomeasure the activity of FBPase, the HL-1 cells were detached from
the cultureﬂask by trypsinization, pelletedbycentrifugation (500×g for
5 min.), re-suspended in culture medium and counted. They were then
centrifuged again and homogenized with Ultra Turrax T8 homogenizer
(IKA Labortechnik) in ice-cold buffer consisting of 20 mM Tris, pH 7.5,
10mMNaCl, 3mMMgCl2,1mMPMSF,1 μg/ml leupeptin and0.1%Triton
X-100. The cells were subsequently centrifuged at 14000 ×g for 10 min.
at 4 °C and the supernatant fraction was assayed for protein
concentration using Bradford Reagent (Fermentas). FBPase activity
was assayed as described in [6]. Measurementswere performedwith an
HP8452Adiode array spectrophotometer. One unit of enzyme activity is
deﬁned as the amount of the enzyme that catalyses the formation of
1 μmol of product per minute.
2.10. Statistical analysis
Collected data was analyzed using Microsoft Excel 2000 and SISA
software (Simple Interactive Statistical Analysis — http://www.quanti-
tativeskills.com/sisa). Results are expressed as mean and standard
deviation (S.D.). For an evaluation of statistical signiﬁcance a Student's t-
test was used. A probability of pb0.05 was considered to represent a
signiﬁcant difference.
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Data presented here represents the results of at least three
independent experiments.
3.1. Expression, activity and subcellular localization of FBPase in HL-1
cardiomyocytes
As there is no existing literature on FBPase in HL-1 cells, ﬁrst we
attempted to determine the activity, isozyme type and localization of
the enzyme in the HL-1 cardiomyocytes, maintained in the standard
Claycomb Medium [18].
After harvesting from the culture ﬂask, the cells were counted in a
Thom-Zeiss chamber, and the FBPase activity was released by
homogenization as described in Materials and methods. Measured
activity was 1.05 nU per one HL-1 cell which corresponded to ca.
4.8 mU/mg of protein.
An electrophoretic analysis of the PCR products showed a speciﬁc
band of the expected length of 383-bp only when the muscle-speciﬁc
primers were used (Fig. 1). It suggests that HL-1 cells express only one
FBPase isozyme: muscle.
To determine the subcellular localization of FBPase, ﬂuorescence
microscopy was used. Incubation of ﬁxed HL-1 cells with rabbit
polyclonal anti-muscle FBPase antibody and secondary FITC-conju-
gated antibody resulted in positive staining of the cytoplasm as well
as the nuclei of the cells, with a visibly stronger staining of the latter
(Fig. 2A).
A more careful examination of the cells revealed three types of
FBPase localization, not related to differences in cells' morphology or
conﬂuency. About 85% of the cells were characterized by a strong
staining in the nuclei and slightly weaker in the cytoplasm (Fig. 2A, D
and G). About 10% of the cells showed a homogeneous nucleo-
cytoplasmic staining (Fig. 2B, E and G), and the nuclei could be
distinguished only by additional DAPI counterstaining (not shown).
Less than 5% of the HL-1 cells completely lacked nuclear FBPase (Fig.
2C, F and G). In all cases no labeling occurred when the primary
antibody was omitted or when the normal serumwas used instead of
the primary antibody.
3.2. Western blot analysis
Rabbit polyclonal antibodies against muscle FBPase were tested by
immunoblotting for their speciﬁcity and their ability to detect FBPase
in HL-1 cells. Whole cell lysate was resolved by 10% SDS-polyacryla-
mide gel electrophoresis. Proteins were transferred onto a nitrocellu-Fig. 1. Results of RT-PCR detection of mRNA of FBPase isozymes in total RNA isolated
from HL-1 cells. Lane A: with speciﬁc primers for mouse muscle FBPase; Lane C: with
speciﬁc primers for mouse liver FBPase (lane C). Lane B: DNA size standards (50 bp–
10000 bp).lose membrane, and a Western blot analysis was conducted as
described previously [12]. The results showed one band of 37 kDa in
the HL-1 cells extract, which migrated identically to the puriﬁed
muscle FBPase used as a control, indicating that antibodies against
muscle FBPase react with FBPase, but do not react with other proteins
from HL-1 cells (Fig. 3).
3.3. The effect of norepinephrine (NE) withdrawal on FBPase localization
Withdrawal of NE from culture medium resulted in time-
dependent changes to the subcellular localization of FBPase in the
HL-1 cardiomyocytes. As early as 1 h after switching the cells to NE-
free medium, the amount of cells lacking nuclear FBPase staining
started to increase (Fig. 4A–C). After 2 days of culture in NE-free
conditions about 90% of cells were depleted of nuclear FBPase (Fig.
4A–D). Adding low concentrations of Leptomycin B (LMB,10 ng/ml), a
speciﬁc inhibitor of the nuclear export factor CRM1 [20], was sufﬁcient
to completely inhibit the FBPase withdrawal from the nucleus (data
not shown), which suggests that a functional nuclear export signal
(NES) is required to translocate FBPase to the cytoplasm.
In addition, the number of cells in NE-free medium was counted
and compared with that maintained in a complete medium. After as
little as two days of culture, the amount of cells in NE-free medium
was signiﬁcantly lower (1.9-fold, S.D.=0.22, p=0.007) than the
amount of cells in NE-supplemented medium. Since the two cultures
did not differ in cell viability (which in both cases was identical and
reaching 98% of cells), the divergence in the number of cardiomyo-
cytes could be a result of a slower cell division rate of the cells which
had been NE-deprived and thus, lacking nuclear FBPase.
3.4. Isoproterenol and metoprolol stimulation
β-adrenergic receptors (β-AR) play a critical role in the regulation
of cardiac function in response to catecholamines [21]. In order to
deﬁne the signal transduction pathway involved in NE-induced
FBPase transport to the nucleus, we ﬁrst investigated the effect of
isoproterenol (ISO), a nonselective β-AR agonist [22], on the nucleo-
cytoplasmic shuttling of FBPase.
The investigation showed that 10 μM ISO abolishes the effect of NE
withdrawal on the localization of FBPase in HL-1 cells. FBPase
remained in the nucleus in about 55% of the cardiomyocytes kept
for 24 h in an NE-free, ISO-supplementedmedium (Fig. 5A–B). Similar
results were obtained by incubating cells in NE-free conditions and
then replenishing themediumwith NE for 24 h (50.5% of cells showed
a strong nuclear FBPase accumulation; data not shown on Figure).
These results demonstrate well the relatively slow rate of nuclear
accumulation of FBPase. In a control experiment (cells kept in NE-free
medium), a strong nuclear accumulation of FBPase was observed in
only about 7% of cells (Fig. 5A).
It is known that, at concentrations greater than 10 μM, ISO can also
stimulate the α-adrenergic receptors (α-AR). However, stimulation of
HL-1 cells with 20 μM did not result in further accumulation of FBPase
in the nuclei, suggesting that α-ARs are not involved in the process.
The predominant subtype of β-ARs in HL-1 cardiac myocytes is the
β1 adrenergic receptor (β1-AR) [21]. It prompted us to further
investigate whether selective stimulation of this receptor induces
nuclear import of FBPase. The cells growing in NE-supplemented
culture medium were treated with metoprolol (MTP; 10 μM), a
selective antagonist of β1-AR [23]. After 24 h of stimulation, FBPase
was observed solely in the cytoplasmic compartment in about 90% of
the cells (Fig. 5C–D).
In another set of experiments, HL-1 cells cultured in NE-free
medium were stimulated with ISO and subsequently with MTP. It
appeared that ISO-induced nuclear accumulation of FBPase was being
suppressed by MTP (Fig. 5E–F). Following such stimulation, nuclear
FBPase was not detected in a prevailing majority of the cells (ca 80%).
Fig. 2. Three types of FBPase subcellular localization in HL-1 cells shown by immunoﬂuorescence (A–C; Bar=20 μm) and ﬂuorescence intensity measurement (D–F). A and D:
Predominantly nuclear localization of FBPase. B and E: Homogeneous nucleo-cytoplasmic location. C and F: HL-1 cells completely lacking nuclear FBPase. G: Percentage of HL-1 cells
in each of the three categories: N — cells with predominantly nuclear FBPase, NC — cells with homogeneous nucleo-cytoplasmic FBPase location. C — cells having only cytoplasmic
FBPase. Each value represents the mean and S.D. of at least three individual experiments.
Fig. 3. Immunoblot testing speciﬁcity of anti-muscle FBPase polyclonal antibodies. A:
20 μg of HL-1 cells homogenate. B: 37-kDa band representing puriﬁed muscle FBPase
(5 μg).
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block with LMB (10 ng/ml), FBPase remained nuclear (Fig. 5G–H),
which proves again that accumulation of the enzyme in the nucleus is
an active, nuclear pore-dependent process rather than a result of the
nuclear envelope damage. Assessment of quantity and viability of the
cells has shown that ISO mimics the accelerating effect of NE on cell
proliferation. MTP does not slow the proliferation rate, but it increases
mortality of HL-1 cells about 3-fold (S.D.=1).
3.5. Role of cAMP-dependent PKA in nuclear accumulation of FBPase
According to the classic view of the β1-AR signal transduction, the
agonist-bound receptor activates adenylyl cyclase (AC) through the
stimulatory Gs protein. AC produces a secondmessenger, cAMP, which
then activates cAMP-dependent kinase A (PKA). Proteins phosphory-
lated by PKA inﬂuence processes such as growth, death and
differentiation of many cell types [24].
In order to conﬁrm that the β1-stimulated signaling pathway is
engaged in the activation of FBPase targeting to the nucleus,
cardiomyocytes preincubated with NE-free medium for 48 h were
treated with 10 μM forskolin, an adenylyl cyclase activator. Followingthe treatment, the subcellular localization of FBPase resembled that in
ISO-treated cells, with about 50% of cardiomyocytes displaying strong
FBPase accumulation in the nucleus, comparedwith only 2% in control
Fig. 4. Time-dependent changes in subcellular localization of FBPase in HL-1 cells after withdrawal of norepinephrine from culture medium. A: Percentage of cells with
predominantly nuclear FBPase. B: Percentage of cells with homogeneous nucleo-cytoplasmic FBPase location. C: Cells lacking nuclear FBPase. Each value represents themean and S.D.
of at least three individual experiments. D: Immunoﬂuorescent localization of FBPase in HL-1 cells after 48 h of culture in NE-free conditions. Bar=20 μm.
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participation of PKA in the activation of nuclear import of FBPase.
To further validate this data, we investigated the effect of a PKA
inhibitor, KT 5720 (2 μM), on the subcellular localization of FBPase in
cardiomyocytes cultured in NE-supplementedmedium. The cells were
treated as described in Materials andmethods and the number of cells
containing nuclear FBPase was counted. Inhibition of PKA activity
appeared to be sufﬁcient to abolish the NE-evoked nuclear transport
of FBPase (Fig. 6C–D). The obtained results suggest collectively that
the β1 receptor-stimulated Gs protein is involved in the transport.
3.6. Inhibition of PI3K
Research has demonstrated that PKA is not the only target of cAMP.
This second messenger also exerts its cellular effects through
phosphoinositide 3-kinase [25]. PI3K acting together with PKA can
regulate cell survival, proliferation and differentiation [25,26].
Examining the effect of PI3K inhibition on nuclear FBPase, we have
found that the addition of 1 μM wortmannin to culture medium
reduced the amount of nuclear FBPase (Fig. 6E–F).
4. Discussion
We have presented evidence that, in HL-1 cardiomyocytes, nuclear
targeting of FBPase is controlled by the β-1 adrenergic receptor-
activated Gs protein signaling cascade.
The physiological role of muscle FBPase, present in a wide range of
non-gluconeogenic cells, is not yet fully understood. Our previous
research has shown that muscle FBPase localizes in the nuclei of
several cell types: cardiac, smooth muscle and dividing muscle
satellite cells, and the current study has managed to extend this list
to include HL-1 cardiomyocytes. These immortalized cells not only
divide continuously, but they also display morphological and
biochemical properties of differentiated cardiac cells, thereforebeing a convenient model to study normal cardiomyocyte functions,
with regard to signaling and metabolic regulation [17].
We have presented evidence that only muscle FBPase is detectable
within HL-1 cells. This is consistent with past ﬁndings of the Eschrich's
group, which showed that in rat heart cells expression of FBPase is
almost exclusively limited to the muscle isozyme [3].
Results of our preliminary experiments reveal that, in contrast to
the liver isozyme, which plays the main role in gluconeogenesis
regulation [2,16], neither elevation nor subsequent withdrawal of
glucose have an effect on the nuclear localization of muscle FBPase
(data not shown). This might suggest that the cellular function of the
enzyme in muscle tissue goes far beyond participation in glycogen
synthesis from carbohydrate precursors.
Subcellular localization of the muscle FBPase isozyme seems to
change, depending on the differentiation stage of the cell [14]. One of
the factors critical to maintaining a differentiated phenotype of HL-1
cell line is norepinephrine [17,18]. To identify the signals involved in
the nuclear targeting of muscle FBPase, we examined the effect of NE
withdrawal on FBPase localization in HL-1 cardiomyocytes.
In the presence of NE (that is, in standard culture medium for HL-
1), approximately 85% of the HL-1 cells contained high levels of FBPase
in the nucleus, in addition to the cytoplasm. This distribution was
expected, and it is consistent with our previous experiments on
vertebrate heart muscle tissue, showing that FBPase is a nucleo-
cytoplasmic enzyme [7,12]. When the HL-1 cells were examined
following a shift to NE-free medium, it appeared that the amount of
nuclear FBPase decreased in a time-dependent manner, and after 48 h
nuclear FBPase was undetectable with indirect immunoﬂuorescence
in a vast majority of the cardiomyocytes. This withdrawal of FBPase
was then effectively blocked by a speciﬁc inhibitor of nuclear export—
Leptomycin B, suggesting that FBPase translocation to cytoplasm is an
active, NES-dependent process.
β-ARs family play a critical role in regulating cardiac function in
response to catecholamines, and β1-AR is the predominant subtype
Fig. 5. Changes in subcellular localization of FBPase in HL-1 cells: A and B: after addition
of nonselective β-AR agonist (10 μM ISO) to cardiomyocytes preincubated with NE-free
medium (control); C and D: after addition of selective β1-AR antagonist (10 μMMTP) to
cells preincubated with NE-containing culture medium (control); E and F: after
stimulation of cells with ISO (control) and successively with MTP; G and H: after
addition of Leptomycin B (LMB) to cells from experiment described in E and F (control).
N — cells with predominantly nuclear FBPase, NC — cells with homogeneous nucleo-
cytoplasmic FBPase location, C — cells having only cytoplasmic FBPase. Each value
represents the mean and S.D. of at least three individual experiments. Bar on Figs. B, D, F
and H = 20 μm.
Fig. 6. Changes in subcellular localization of FBPase inHL-1 cells: A and B: after addition of
10 μM forskolin to cardiomyocytes preincubatedwith NE-freemedium (control); C and D:
after addition of KT 5720 (a PKA inhibitor; 2 μM) to cardiomyocytes preincubatedwith NE-
containing culture medium (control); E and F: after addition of 1 μMwortmannin, a PI3K
inhibitor, to cells preincubated with NE-containing culture medium. N — cells with
predominantly nuclear FBPase, NC — cells with homogeneous nucleo-cytoplasmic FBPase
location, C— cells havingonly cytoplasmic FBPase. Each value represents themean andS.D.
of at least three individual experiments. Bar on B, D and F = 20 μm.
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enters the nucleus following the activation of β1-ARs. This hypothesis
was conﬁrmed through our experiments with ISO (a nonselective β-
AR agonist) and with MTP (a selective antagonist of β1-AR). ISO
mimicked the stimulatory effect of NE on nuclear accumulation of
FBPase, and this effect was, in turn, suppressed by MTP.
Searching for further validation of our ﬁndings, we discovered that
in the absence of NE, the activation of adenylyl cyclase by forskolin is
sufﬁcient to stimulate FBPase targeting to the nucleus. On the other
hand, inhibition of cAMP-dependent PKA effectively abolishes the NE-
activated nuclear transport of FBPase. These ﬁndings suggest a role of
PKA-dependent phosphorylation in the nucleo-cytoplasmic shuttling
of the enzyme. However, although we have demonstrated that muscle
FBPase might be a substrate for PKA [27], the relatively slow rate of
FBPase translocation might suggest that an additional modiﬁcation of
FBPase is necessary for the nuclear localization of the enzyme.NE-stimulated PKA activation is an important step in the process of
cellular growth and differentiation of cardiac myocytes [28]. However,
many lines of evidence suggest that it is β2-ARs (rather than β1-ARs)
which are responsible for the mitogenic effect of catecholamines (for
example see [29]). Our results demonstrate that the NE signaling
accelerates the rate of HL-1 proliferation signiﬁcantly (about twofold).
The same effect is achieved by substituting NE with a β-AR agonist,
while a selective β1-AR antagonist does not slow the proliferation rate.
Consequently, it seems that a β1-AR-dependent nuclear localization of
FBPase is not directly connected with the accelerating effect of NE on
cell proliferation. However, a disruption of β1-AR signaling increases
the mortality of HL-1 cells about threefold.
Although pharmacological studies from the end of the 20th
century suggested that β1-AR induces a cAMP-dependent apoptosis
[30], more recently it has been demonstrated that cAMP, acting
through PKA, may be a crucial anti-apoptotic factor in cardiac
myocytes [31]. cAMP can also stimulate PI3K, and the signaling
cascades activated by PKA and PI3K jointly contribute to the cAMP-
afforded cell survival [26,31]. Here we demonstrate that inhibition of
PI3K results in FBPase withdrawal from the nucleus of cardiomyo-
cytes. These results point to the conclusion that both of the kinases
promoting anti-apoptotic pathways also activate nuclear translocation
of FBPase in HL-1 cells.
Available data on the nongluconegenic role of FBPase is incon-
sistent: it has been suggested that FBPasemight be a proapoptotic [32]
or an anti-apoptotic protein [33]. cAMP can either inhibit or stimulate
cell growth and survival, depending on the cell type (for example see
[26]), and it is not unlikely that the same might be true for FBPase.
877A. Gizak et al. / Biochimica et Biophysica Acta 1793 (2009) 871–877Whatever its additional role, the enzyme appears to be more than just
a component of the glyconeogenic pathway.
Taken together, the obtained results offer strong evidence that, in
HL-1 cardiomyocytes, nuclear transport of FBPase is a controlled
process, mediated by norepinephrine acting through β1 receptors and
the Gs protein signaling cascade. These ﬁndings motivate future
studies to clarify the link between nuclear localization of FBPase and
the regulation of the cardiomyocyte cell survival, and to unravel all
components of the signaling pathway regulating nuclear transport of
the enzyme.
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